Showing results (211-220 of 550) with videos related to
Sort By:
Pageof 55
Neoplasia (New York, N.Y.)|November 9, 2013
Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibitionSumin Han, J Chad Brenner, Aaron Sabolch, et al.Neoplasia (New York, N.Y.)|April 9, 2014
Efficacy of an EGFR-specific peptide against EGFR-dependent cancer cell lines and tumor xenograftsAarif Ahsan, Susmita G Ramanand, Ingrid L Bergin, et al.Neoplasia (New York, N.Y.)|July 14, 2011
Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2Dipankar Ray, Aarif Ahsan, Abigail Helman, et al.International Journal of Radiation Oncology, Biology, Physics|February 24, 2009
Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and MichiganLujun Zhao, Luhua Wang, Wei Ji, et al.The Journal of Biological Chemistry|July 31, 2013
Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerizationAarif Ahsan, Dipankar Ray, Susmita G Ramanand, et al.Translational Oncology|March 10, 2015
Targeting mcl-1 for radiosensitization of pancreatic cancersDongping Wei, Qiang Zhang, Jason S Schreiber, et al.European Urology|February 25, 2017
Vessel-sparing Radiotherapy for Localized Prostate Cancer to Preserve Erectile Function: A Single-arm Phase 2 TrialDaniel E Spratt, Jae Y Lee, Robert T Dess, et al.International Journal of Radiation Oncology, Biology, Physics|July 28, 2004
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabineAaron M Allen, Mark M Zalupski, John M Robertson, et al.Medical Physics|March 29, 2007
Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functionsAaron C Spalding, Kyung-Wook Jee, Karen Vineberg, et al.Journal of the National Cancer Institute|February 25, 2015
A statistical evaluation of dose expansion cohorts in phase I clinical trialsPhilip S Boonstra, Jincheng Shen, Jeremy M G Taylor, et al.Pageof 55